• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV感染的发病机制

Pathogenesis of HIV Infection.

作者信息

Naif Hassan M

机构信息

Molecular Virology Program, Medical Biotechnology, Al-Nahrain University , Baghdad, Iraq.

出版信息

Infect Dis Rep. 2013 Jun 6;5(Suppl 1):e6. doi: 10.4081/idr.2013.s1.e6.

DOI:10.4081/idr.2013.s1.e6
PMID:24470970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3892619/
Abstract

Over the past three decades of intense research on the contribution of viral and host factors determining the variability in HIV-1 infection outcome, HIV pathogenesis is still a fascinating topic that requires further study. An understanding of the exact mechanism of how these factors influencing HIV pathogenesis is critical to the development of effective strategies to prevent infection. Significant progress has been made in identifying the role of CCR5 (R5) and CXCR4 (X4) HIV strains in disease progression, particularly with the persistence of R5 HIV-1 strains at the AIDS stage. This indicates that R5 strains are as fit as X4 in causing CD4+ T cell depletion and in contribution to disease outcome, and so questions the prerequisite of the shift from R5 to X4 for disease progression. In contrast, the ability of certain HIV strains to readily use CXCR4 for infection or entry into macrophages, as the case with viruses are homozygous for tropism by CCR5delta32. This raises another major paradox in HIV pathogenesis about the source of X4 variants and how do they emerge from a relatively homogeneous R5 viral population after transmission. The interactions between viral phenotypes, tropism and co-receptor usage and how they influence HIV pathogenesis are the main themes addressed in this review. A better understanding of the viral and host genetic factors involved in the fitness of X4 and R5 strains of HIV-1 may facilitate development of specific inhibitors against these viral populations to at least reduce the risk of disease progression.

摘要

在过去三十年对决定HIV-1感染结果变异性的病毒和宿主因素贡献的深入研究中,HIV发病机制仍然是一个引人入胜且需要进一步研究的课题。了解这些因素影响HIV发病机制的确切机制对于制定有效的预防感染策略至关重要。在确定CCR5(R5)和CXCR4(X4)HIV毒株在疾病进展中的作用方面已经取得了重大进展,特别是R5 HIV-1毒株在艾滋病阶段的持续存在。这表明R5毒株在导致CD4+T细胞耗竭和对疾病结果的贡献方面与X4毒株一样合适,因此对疾病进展从R5向X4转变的前提条件提出了质疑。相比之下,某些HIV毒株能够轻易利用CXCR4进行感染或进入巨噬细胞,就像CCR5delta32纯合性病毒那样。这在HIV发病机制中引发了另一个主要悖论,即X4变体的来源以及它们在传播后如何从相对同质的R5病毒群体中出现。病毒表型、嗜性和共受体使用之间的相互作用以及它们如何影响HIV发病机制是本综述探讨的主要主题。更好地了解参与HIV-1 X4和R5毒株适应性的病毒和宿主遗传因素可能有助于开发针对这些病毒群体的特异性抑制剂,以至少降低疾病进展的风险。

相似文献

1
Pathogenesis of HIV Infection.HIV感染的发病机制
Infect Dis Rep. 2013 Jun 6;5(Suppl 1):e6. doi: 10.4081/idr.2013.s1.e6.
2
Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.HIV-1 感染者血浆中存在具有不同核心受体使用偏好的复制型次要变异体。
J Virol. 2020 Jun 1;94(12). doi: 10.1128/JVI.00193-20.
3
Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.在感染过程中,开关(R5 到 R5X4/X4-嗜性)和非开关(仅 R5-嗜性)HIV-1 群体之间的分子进化差异。
Infect Genet Evol. 2010 Apr;10(3):356-64. doi: 10.1016/j.meegid.2009.05.003. Epub 2009 May 14.
4
Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.近期感染后HIV-1感染者中辅助受体嗜性转换的速度
J Virol. 2017 Sep 12;91(19). doi: 10.1128/JVI.00793-17. Print 2017 Oct 1.
5
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.抑制原发性淋巴细胞和巨噬细胞中双重/混合嗜性 HIV-1 分离物的 CCR5 抑制剂。
PLoS One. 2013 Jul 9;8(7):e68076. doi: 10.1371/journal.pone.0068076. Print 2013.
6
The role of viral coreceptors and enhanced macrophage tropism in human immunodeficiency virus type 1 disease progression.病毒共受体及增强的巨噬细胞嗜性在1型人类免疫缺陷病毒疾病进展中的作用。
Sex Health. 2004;1(1):23-34. doi: 10.1071/sh03006.
7
Pathogenesis of macrophage tropic HIV-1.嗜巨噬细胞性HIV-1的发病机制
Curr HIV Res. 2005 Jan;3(1):53-60. doi: 10.2174/1570162052772951.
8
Higher prevalence of predicted X4-tropic strains in perinatally infected older children with HIV-1 subtype C in India.在印度,感染 HIV-1 亚型 C 的围产期感染的年长儿童中,预测的 X4 嗜性株的流行率更高。
J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):347-53. doi: 10.1097/QAI.0b013e3182405c7b.
9
Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses.在已产生合胞体诱导性、趋化因子受体CXCR4型病毒的艾滋病患者中,对趋化因子受体CCR5型1型人类免疫缺陷病毒变异体进行纯化选择。
J Gen Virol. 2006 May;87(Pt 5):1285-1294. doi: 10.1099/vir.0.81722-0.
10
HIV-1 coreceptor usage, transmission, and disease progression.HIV-1共受体的使用、传播及疾病进展。
Curr HIV Res. 2003 Apr;1(2):217-27. doi: 10.2174/1570162033485357.

引用本文的文献

1
Hematological Profiles of Adults Coinfected With HIV and Malaria Receiving Highly Active Antiretroviral Therapy at Bonga Gebretsadik Shawo General Hospital, Southwest Ethiopia: A Comparative Cross-Sectional Study.埃塞俄比亚西南部邦加·格布雷萨迪克·沙沃综合医院接受高效抗逆转录病毒治疗的成人HIV与疟疾合并感染患者的血液学特征:一项比较性横断面研究
Adv Hematol. 2025 Aug 21;2025:3894305. doi: 10.1155/ah/3894305. eCollection 2025.
2
Safety and Efficacy of Immune Checkpoint Inhibitors in Human Immunodeficiency Virus-Associated Cancer: A Systematic Scoping Review.免疫检查点抑制剂在人类免疫缺陷病毒相关癌症中的安全性和有效性:一项系统综述。
Diseases. 2025 Jul 22;13(8):230. doi: 10.3390/diseases13080230.
3

本文引用的文献

1
HIV reservoirs: pathogenesis and obstacles to viral eradication and cure.HIV 储库:发病机制以及病毒清除和治愈的障碍。
AIDS. 2012 Jun 19;26(10):1261-8. doi: 10.1097/QAD.0b013e328353f3f1.
2
Chemokines and chemokine receptors in susceptibility to HIV-1 infection and progression to AIDS.趋化因子及其受体与 HIV-1 易感性及艾滋病进展的关系。
Dis Markers. 2012;32(3):143-51. doi: 10.3233/DMA-2011-0874.
3
Pathogenesis of HIV in the central nervous system.HIV 在中枢神经系统中的发病机制。
Polymeric and lipidic nanoparticles in transforming anti-HIV combinational therapy: can they turn the tide?
聚合物和脂质纳米颗粒在抗HIV联合治疗中的转化应用:它们能否扭转局面?
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 23. doi: 10.1007/s00210-025-04169-w.
4
How to properly define immunological nonresponse to antiretroviral therapy in people living with HIV? an integrative review.如何正确定义HIV感染者对抗逆转录病毒治疗的免疫无应答?一项综合性综述。
Front Immunol. 2025 Apr 7;16:1535565. doi: 10.3389/fimmu.2025.1535565. eCollection 2025.
5
The HIV-1 R77Q Mutant Induces Apoptosis, G Cell Cycle Arrest, and Lower Production of Pro-Inflammatory Cytokines in Human CD4+ T Cells.HIV-1 R77Q 突变体诱导人 CD4+T 细胞凋亡、G 期细胞周期停滞和促炎细胞因子产生减少。
Viruses. 2024 Oct 21;16(10):1642. doi: 10.3390/v16101642.
6
Low prevalence of HIV in the northern Cameroon: contribution of some AIDS restriction genes and potential implications for gene therapy.喀麦隆北部地区人类免疫缺陷病毒(HIV)低流行率:某些艾滋病限制基因的作用及其对基因治疗的潜在影响
Front Genet. 2024 Sep 13;15:1447971. doi: 10.3389/fgene.2024.1447971. eCollection 2024.
7
Modelling the role of tourism in the spread of HIV: A case study from Malaysia.模拟旅游业在艾滋病毒传播中的作用:以马来西亚为例的案例研究。
Heliyon. 2024 Aug 8;10(16):e35896. doi: 10.1016/j.heliyon.2024.e35896. eCollection 2024 Aug 30.
8
Interventions for tobacco use cessation in people living with HIV.HIV 感染者的戒烟干预措施。
Cochrane Database Syst Rev. 2024 Aug 5;8(8):CD011120. doi: 10.1002/14651858.CD011120.pub3.
9
Unraveling clinical outcomes of long-term cART treatment in HIV-1 patients with or without the Brazilian GWGR motif in the V3 loop.解析 HIV-1 患者 V3 环中是否存在巴西 GWGR 基序对长期 cART 治疗临床结局的影响。
Rev Inst Med Trop Sao Paulo. 2024 Jul 8;66:e38. doi: 10.1590/S1678-9946202466038. eCollection 2024.
10
HIV-Induced Thymic Insufficiency and Aging-Related Immunosenescence on Immune Reconstitution in ART-Treated Patients.HIV 诱导的胸腺功能不全和与衰老相关的免疫衰老对接受抗逆转录病毒治疗患者免疫重建的影响
Vaccines (Basel). 2024 Jun 4;12(6):612. doi: 10.3390/vaccines12060612.
Curr HIV/AIDS Rep. 2011 Mar;8(1):54-61. doi: 10.1007/s11904-010-0070-4.
4
Pathogenic mechanisms of HIV disease.HIV 疾病的发病机制。
Annu Rev Pathol. 2011;6:223-48. doi: 10.1146/annurev-pathol-011110-130254.
5
Phenotype variation in human immunodeficiency virus type 1 transmission and disease progression.人类免疫缺陷病毒1型传播与疾病进展中的表型变异
Dis Markers. 2009;27(3):121-36. doi: 10.3233/DMA-2009-0656.
6
Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.在感染过程中,开关(R5 到 R5X4/X4-嗜性)和非开关(仅 R5-嗜性)HIV-1 群体之间的分子进化差异。
Infect Genet Evol. 2010 Apr;10(3):356-64. doi: 10.1016/j.meegid.2009.05.003. Epub 2009 May 14.
7
The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands.常见的γ链细胞因子白细胞介素-2、白细胞介素-7、白细胞介素-15和白细胞介素-21可诱导程序性死亡-1及其配体的表达。
J Immunol. 2008 Nov 15;181(10):6738-46. doi: 10.4049/jimmunol.181.10.6738.
8
25 years of HIV.艾滋病流行25年。
Nature. 2008 May 15;453(7193):289-90. doi: 10.1038/453289a.
9
HIV-associated opportunistic infections. Bacterial infections.HIV相关机会性感染。细菌感染。
J Med Liban. 2006 Apr-Jun;54(2):80-3.
10
Human immunodeficiency virus-mononuclear phagocyte interactions: emerging avenues of biomarker discovery, modes of viral persistence and disease pathogenesis.人类免疫缺陷病毒与单核吞噬细胞的相互作用:生物标志物发现、病毒持续存在模式及疾病发病机制的新途径
Curr HIV Res. 2006 Jul;4(3):279-91. doi: 10.2174/157016206777709474.